Drawing for RIPPLE

USPTO serial 99199223

RIPPLE

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ANDERSON, ELIZABETH C
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with RIPPLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas J. Perkowski

Thomas J. Perkowski Thomas J. Perkowski, ESQ., PC6 Thorndal CircleSecond FloorDarien, CT 06820-5415

Goods and services

ClassDescriptionStatusFirst use
005Gels and ointments for ophthalmic use, namely, ophthalmic gel and ointment preparation for promoting eye health and human vision for optimum eye function; Artificial tears, namely, artificial tears in gel and ointment form for the provision of ocular surface lubrication; Artificial tears, namely, artificial tears in eye drop form for the provision of ocular surface lubrication; Gels and ointments for ophthalmic use, namely, ophthalmic eye gel and ointment for eyelid exfoliation, optimization of meibomian gland function and promoting eyelid function; Artificial tears, namely, preservative-free artificial tears preparations in sterile ophthalmic gel and ointment form for preserving the ocular surface; Artificial tears, namely, preservative-free artificial tears preparations in sterile eye drop form for preserving the ocular surface; Contact lens compatible artificial tears, namely, artificial tears in eye drop form for the provision of contact lens and ocular surface lubrication; Contact lens compatible artificial tears, namely, preservative-free artificial tears in eye drop form for preserving the ocular surface.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 16, 2026EX1GSOU EXTENSION 1 GRANTED—
Oct 16, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 16, 2026TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jun 16, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Jun 16, 2026PETGPETITION TO REVIVE-GRANTED—
Jun 16, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Jun 2, 2026EXT1SOU EXTENSION 1 FILED—
Dec 2, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 7, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 7, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 1, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 9, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 15, 2025DOCKASSIGNED TO EXAMINER—
May 23, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 23, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 23, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance